Return on Investments: An indicator of how profitable a company is relative to its assets invested by shareholders and long-term bond holders. Calculated by dividing a company's operating earnings by its long-term debt and shareholders equity. Calculated as: Income from Continuing Operations / (Total Long-Term Debt + Shareholders Equity)
Pyxis Oncology, Inc. (PYXS) had Return on Investments of -20.94% for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
$2.82M |
|
$-18.35M |
|
-- |
|
$2.82M |
|
$22.57M |
|
$-19.75M |
|
$1.68M |
|
$-18.07M |
|
$-18.07M |
|
$-18.35M |
|
$-18.35M |
|
$-18.35M |
|
$-18.35M |
|
$-19.75M |
|
$-20.11M |
|
61.92M |
|
61.92M |
|
$-0.30 |
|
$-0.30 |
|
| Balance Sheet Financials | |
$99.96M |
|
$8.92M |
|
$23.26M |
|
$123.22M |
|
$17.68M |
|
-- |
|
$17.89M |
|
$35.57M |
|
$87.64M |
|
$85.16M |
|
$87.64M |
|
62.02M |
|
| Cash Flow Statement Financials | |
$-39.80M |
|
$31.12M |
|
$-0.07M |
|
$20.95M |
|
$12.21M |
|
$-8.74M |
|
$6.65M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
5.65 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-700.35% |
|
-700.35% |
|
-- |
|
-640.82% |
|
-650.85% |
|
$-39.80M |
|
-- |
|
-- |
|
-- |
|
0.02 |
|
-- |
|
0.94 |
|
95.74 |
|
-20.94% |
|
-21.55% |
|
-14.90% |
|
|
Return on Investments |
-20.94% |
$1.41 |
|
$-0.64 |
|
$-0.64 |
|